Andrea Costamagna
Overview
Explore the profile of Andrea Costamagna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costamagna A, Balzani E, Marro M, Simonato E, Burello A, Rinaldi M, et al.
Transpl Int
. 2025 Feb;
38:13794.
PMID: 39944219
Systematic Review Registration: https://osf.io/gkxzh/.
2.
Ghiglione N, Abbo D, Bushunova A, Costamagna A, Porporato P, Martini M
Mol Metab
. 2024 Dec;
92:102089.
PMID: 39736443
Background: Cellular metabolism plays a pivotal role in the development and progression of pancreatic ductal adenocarcinoma (PDAC), with dysregulated metabolic pathways contributing to tumorigenesis and therapeutic resistance. Distinct metabolic heterogeneity...
3.
Pocar M, Barbero C, Costamagna A, Rinaldi M, Brazzi L
Front Cardiovasc Med
. 2024 Dec;
11:1524314.
PMID: 39660119
No abstract available.
4.
Loforte A, Marro M, Simonato E, Costamagna A, Ellena M, Trompeo A, et al.
Ann Cardiothorac Surg
. 2024 Dec;
13(6):522-530.
PMID: 39649630
In the last decade, heart transplants using allografts from adult donors after circulatory death, in a controlled setting, controlled donation after circulatory death (cDCD) have been rapidly adopted and widely...
5.
Costamagna A, Pasquino C, Lamorte S, Navarro-Tableros V, Delsedime L, Fanelli V, et al.
Intensive Care Med Exp
. 2024 Dec;
12(1):111.
PMID: 39627601
Background: Sepsis is a condition with high mortality and morbidity, characterized by deregulation of the immune response against the pathogen. Current treatment strategies rely mainly on antibiotics and supportive care....
6.
Barbero C, Pocar M, Costamagna A, Capozza C, Aloi V, Cura Stura E, et al.
J Cardiovasc Dev Dis
. 2024 Nov;
11(11).
PMID: 39590201
Objective: Redo mitral valve surgery still represents a challenging and high-risk procedure in cardiac surgery. The incidence of cardiac structural injuries during re-sternotomy remains consistent and is reported to be...
7.
Boffini M, Costamagna A, Marro M, Simonato E, Cassoni P, Bertero L, et al.
Transpl Int
. 2024 Aug;
37:13178.
PMID: 39144835
The key goal in lung donation remains the improvement of graft preservation with the ultimate objective of increasing the number and quality of lung transplants (LTx). Therefore, in recent years...
8.
Pocar M, Barbero C, Marro M, Ferrante L, Costamagna A, Fazio L, et al.
J Clin Med
. 2024 Aug;
13(15).
PMID: 39124799
Destructive aortic prosthetic valve endocarditis portends a high morbidity and mortality, and requires complex high-risk surgery. Homograft root replacement is the most radical and biocompatible operation and, thus, the preferred...
9.
Barbero C, Pocar M, Brenna D, Costamagna A, Aloi V, Capozza C, et al.
J Clin Med
. 2024 Jun;
13(11).
PMID: 38892855
. Severe tricuspid valve (TV) disease has a strong association with right ventricle dysfunction, heart failure and mortality. Nevertheless, surgical indications for isolated TV disease are still uncommon. The purpose...
10.
Agostini G, Vairo A, Montefusco A, Marro M, Costamagna A, La Torre M, et al.
JACC Case Rep
. 2024 Apr;
29(7):102273.
PMID: 38645293
An 84-year-old man presented with dyspnea at rest due to severe mitral regurgitation. He first underwent transventricular mitral valve repair with the Harpoon system, which relapsed owing to rupture of...